Research Topics
| Mona MarinSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003Mona Marin
Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pediatrics 115:900-5. 2005..We investigated this outbreak to examine reasons for its occurrence, including vaccine failure...
Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006Mona Marin
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS A 47, Atlanta, GA, United States
Vaccine 26:3601-7. 2008..Further studies are needed to examine the persistence of two-dose mumps vaccine-induced immunity and to determine whether US mumps elimination can be achieved with the current vaccination strategy...
Varicella prevention in the United States: a review of successes and challengesMona Marin
Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, MS A 47, Atlanta, GA 30333, USA
Pediatrics 122:e744-51. 2008..The objective of this review was to summarize the US experience with the 1-dose varicella vaccination program, present the evidence considered for the policy change, and outline future challenges of the program...
Near elimination of varicella deaths in the US after implementation of the vaccination programMona Marin
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pediatrics 128:214-20. 2011..Since then, vaccination coverage has increased substantially. We updated the analysis of US varicella mortality for 2002-2007 and assessed the impact of the first 12 years of the US varicella vaccination program on varicella deaths...
Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policyMona Marin
Epidemic Intelligence Service, Epidemiology Program Office, National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS E 61, Atlanta, GA 30333, USA
Clin Infect Dis 42:315-9. 2006..Of outbreak cases, 41% were reported to have been previously vaccinated. We studied measles attack rates in RMI households to assess vaccine effectiveness and patterns of disease transmission...
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)Mona Marin
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
MMWR Recomm Rep 59:1-12. 2010..cdc.gov/vaccines/recs/provisional/downloads/combo-vax-Aug2009-508.pdf), which state that use of a combination vaccine generally is preferred over its equivalent component vaccines...
Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)Mona Marin
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
MMWR Recomm Rep 56:1-40. 2007..ACIP also approved criteria for evidence of immunity to varicella...
Varicella among adults: data from an active surveillance project, 1995-2005Mona Marin
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 197:S94-S100. 2008....
Varicella vaccine effectiveness in the US vaccination program: a reviewJane F Seward
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 197:S82-9. 2008..Monitoring the effectiveness of the newly recommended 2-dose childhood vaccine schedule for varicella vaccine is a priority...
Measles outbreak in the Republic of the Marshall Islands, 2003Terri B Hyde
Viral Vaccine Preventable Diseases Branch, National Immunization Program, NIP, Centers for Disease Control and Prevention, CDC, Atlanta, GA 30333, USA
Int J Epidemiol 35:299-306. 2006..Reported 1-dose measles vaccine coverage among children aged 12-23 months varied widely (52-94%) between 1990 and 2000...
Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, pennsylvania, 2006Michael D Nguyen
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 29:685-9. 2010..We evaluated the effectiveness of this intervention...
Herpes zoster-related deaths in the United States: validity of death certificates and mortality rates, 1979-2007Abdirahman Mahamud
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Clin Infect Dis 55:960-6. 2012..Herpes zoster (HZ) vaccine was recommended in the United States to reduce HZ-associated morbidity. Vaccination may reduce HZ-associated mortality, but no strategy exists to monitor mortality trends...
Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004Carrie M Shuler
Epidemic Intelligence Service, Atlanta, GA, USA
Pediatrics 119:e587-95. 2007..We assessed vaccine effectiveness against medically attended, laboratory-confirmed influenza for children who were aged 6 to 59 months during the 2003-2004 influenza season...
National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccineLaura P Hurley
Department of General Internal Medicine, University of Colorado at Denver and Health Sciences Center, The Children s Hospital, Denver, Colorado, USA
J Infect Dis 197:S216-23. 2008..This study describes physicians' perception of burden associated with herpes zoster (HZ) and postherpetic neuralgia (PHN), intentions for recommending the HZ vaccine, and perceived barriers to vaccination...
Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registryEileen Wilson
Clinical Risk Management and Safety Surveillance, Merck and Co, Inc, West Point, Pennsylvania, USA
J Infect Dis 197:S178-84. 2008..The Pregnancy Registry for Varivax (Merck) was established to monitor for congenital varicella syndrome or other birth defects in the offspring of women who were exposed to varicella vaccine while pregnant...
Physician attitudes regarding breakthrough varicella disease and a potential second dose of varicella vaccineMatthew M Davis
Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, MI, USA
Pediatrics 119:258-64. 2007..We assessed physicians' attitudes about the 1-dose varicella vaccination program and whether physicians think a 2-dose recommendation is needed to reduce the risk of breakthrough disease...
